Protein detail
TNR5
Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)
Protein symbol TNR5 | UniProt ID | EVMP score 0.38 |
Frequency 5 | Transmembrane count 1 | Protein classification Cancer-related genesCD markersDisease related genesHuman disease related genesPredicted membrane proteinsPredicted secreted proteins |
Basic Information
Protein Names
Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)
Protein Class
Cancer-related genesCD markersDisease related genesHuman disease related genesPredicted membrane proteinsPredicted secreted proteins
Protein Function
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Cancer-related genes:Candidate cancer biomarkers
- Predicted secreted proteins
- Disease related genes
Transmembrane
194..215; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym
Bp50p50TNFRSF5
Gene Description
CD40 molecule
Chromosome
20
Position
46118271-46129863
Frequency
5
EVMP Score
0.38
Fluorescence & Localization
Tissue SpecificesophagusCell SpecificEnterocytesSingle-Nuclei Brain Specificastrocyte
Function & Pathway
Protein Function
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Cancer-related genes:Candidate cancer biomarkers
- Predicted secreted proteins
- Disease related genes
Cellular Component
Molecular Function
Biological Process
KEGG
- hsa04060 Cytokine-cytokine receptor interaction
- KEGG:hsa04064 NF-kappa B signaling pathway
- KEGG:hsa04514 Cell adhesion molecule (CAM) interaction
- KEGG:hsa04620 Toll-like receptor signaling pathway
- KEGG:hsa04672 Intestinal immune network for IgA production
- KEGG:hsa05144 Malaria
- KEGG:hsa05145 Toxoplasmosis
- KEGG:hsa05166 Human T-cell leukemia virus 1 infection
- KEGG:hsa05169 Epstein-Barr virus infection
- KEGG:hsa05202 Transcriptional misregulation in cancer
- KEGG:hsa05310 Asthma
- KEGG:hsa05320 Autoimmune thyroid disease
- KEGG:hsa05322 Systemic lupus erythematosus
- KEGG:hsa05330 Allograft rejection
- KEGG:hsa05340 Primary immunodeficiency
- KEGG:hsa05416 Viral myocarditis
- KEGG:hsa05417 Lipid and atherosclerosis
Reactome
- R-hsa-1280218 adaptive immune system
- R-hsa-1280215 cytokine signaling in immune system
- R-hsa-198933 immunoregulatory interactions between a lymphoid and a non lymphoid cell
- R-hsa-5668541 tnfr2 non canonical nf kb pathway
- R-hsa-5676594 tnf receptor superfamily tnfsf members mediating non canonical nf kb pathway
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence
Enzyme-Mediated Modification
0 records.
Ligand-Receptor Signaling
63 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| tumor_necrosis_factor | receptor | Almen2009 | No | Yes | Yes | Yes | No |
| tnf_receptor | receptor | CellPhoneDB | No | Yes | Yes | Yes | No |
| tnfngf | receptor | Surfaceome | No | Yes | Yes | Yes | No |
| checkpoint | receptor | ICELLNET | No | Yes | Yes | Yes | No |
| cytokine | receptor | ICELLNET | No | Yes | Yes | Yes | No |
| cytokine_tnf | receptor | ICELLNET | No | Yes | Yes | Yes | No |
| checkpoint_tnf | receptor | ICELLNET | No | Yes | Yes | Yes | No |
| receptor | receptor | OmniPath | No | Yes | Yes | Yes | No |
| extracellular | extracellular | DGIdb | No | No | Yes | Yes | No |
| extracellular | extracellular | OmniPath | No | No | Yes | Yes | No |
Regulatory Interaction Network
3 records.
Protein Complex Composition
9 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| Membrane-associated multicomponent signaling complexanti-CD40 stimulated (Cd40IkbkgMap3k1Traf2Ube2n) | CD40IKBKGMAP3K1TRAF2UBE2N | P25942P61088Q12933Q13233Q9Y6K9 | 1:1:1:1:1 | Compleat | Compleat:HC2242 | 18635759 |
| Multicomponent signaling complexanti-CD40 stimulated(Birc2Birc3Cd40IkbkgMap3k1Traf2Ube2n) | BIRC2BIRC3CD40IKBKGMAP3K1TRAF2UBE2N | P25942P61088Q12933Q13233Q13489Q13490Q9Y6K9 | 1:1:1:1:1:1:1 | Compleat | Compleat:HC88 | 18635759 |
| CD40LGTNC | P24821P29965 | 1:1 | PDB | PDB:6brb | ||
| CD40 | P25942 | 3 | PDB | PDB:5dmjPDB:7p3iPDB:5ihlPDB:8yx9PDB:6pe9PDB:6pe8PDB:8yx1 | ||
| CD40CD40LG | P25942P29965 | 4:6 | PDB | PDB:3qd6 | ||
| CD40TRAF2 | P25942Q12933 | 2:3 | PDB | PDB:1czzPDB:1d00 | ||
| CD40TRAF3 | P25942Q13114 | 2:2 | PDB | PDB:1fll | ||
| CD40TRAF6 | P25942Q9Y4K3 | 1:1 | PDB | PDB:1lb6 | ||
| CD40LG | P29965 | 3 | CompleatCFinderPDB | PDB:7sgmPDB:1i9rPDB:6w9gPDB:3lkjCompleat:HC7674 |
Isolation & Detection Technology
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential Ultracentrifugation | Mass spectrometryMORPH | 1 | 22808001 |
Sequence, Structure & Domains
Sequences
Length
277
Mass
30,619
Sequence
MVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECLPCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCVLHRSCSPGFGVKQIATGVSDTICEPCPVGFFSNVSSAFEKCHPWTSCETKDLVVQQAGTNKTDVVCGPQDRLRALVVIPIIFGILFAILLVLVFIKKVAKKPTNKAPHPKQEPQEINFPDDLPGSNTAAPVQETLHGCQPVTQEDGKESRISVQERQ
Alternative Products
Event=Alternative splicing; Named isoforms=2; Comment=Additional isoforms seem to exist.; Name=I; IsoId=P25942-1; Sequence=Displayed; Name=II; IsoId=P25942-2; Sequence=VSP_006472, VSP_006473
Alternative Sequence
166..203; SCETKDLVVQQAGTNKTDVVCGPQDRLRALVVIPIIFG -> RSPGSAESPGGDPHHLRDPVCHPLGAGLYQKGGQEANQ (in isoform II); 204..277; Missing (in isoform II)
3D Structural Models
Helix
85..87; 168..170
Beta Strand
30..33; 36..39; 45..49; 53..55; 58..61; 64..67; 70..72; 89..93; 97..99; 102..105; 109..113; 117..121; 129..133; 137..139; 142..145; 156..158; 173..176; 180..182; 185..187; 234..237; 258..260
3D Structure
X-ray crystallography (14)
Domain & Motif Annotations
Compositional Bias
264..277; Basic and acidic residues
Repeat
25..60; TNFR-Cys 1; 61..103; TNFR-Cys 2; 104..144; TNFR-Cys 3; 145..187; TNFR-Cys 4
Region
223..277; Disordered
Clinical Relevance
Disease Involvement
Cancer-related genesDisease variant
Related Diseases
Biomarker
Phase 1; Phase 2; Investigative
Drugs
CDX-1140CD40 LIGANDTETANUS TOXOIDNULLSOTIGALIMABTENELIXIMABRECOMBINANT CD40-LIGANDGILORALIMABDACETUZUMABBLESELUMABPG-102GP-120 ANTIGENSTREPTOZOCINCFZ533ALDESLEUKINLUCATUMUMABSELICRELUMABHYDROQUINONEMONOCLONAL ANTIBODY SGN-14AUTOLOGOUS PROSTATE CANCER ANTIGEN-EXPRESSING DENDRITIC CELL VACCINE BPX-101RAVAGALIMABISCALIMABFLUDARABINEMANNOSE-BINDING LECTIN
Interaction Protein
ENSG00000091317ENSG00000127191ENSG00000131323ENSG00000175104
Interaction Count
4
Interaction Dataset
intact_biogrid_bioplexintact_biogrid